A partir de 15 de janeiro de 2026, aplicar-se-á a nova versão das Orientações sobre os pormenores das diversas categorias de alteração relativas a alterações dos termos das autorizações de introdução no mercado
News & Trends
Procurar
Recentes
- ICH E6(R3) update – New training materials available (Jan 2026)
- 2025 EMA’s key recommendations in human medicines.
- Guiding principles of good AI practice in medicine development
- European Pharmacopoeia publishes new data quality framework
- FDA GUIDANCE DOCUMENT: Clinical Decision Support Software! Guidance for Industry and Food and Drug Administration Staff
- Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products Guidance for Industry
- The Use of Generative Artificial Intelligence in Research
- FDA GUIDANCE ON General Wellness: Policy for Low Risk Devices